News specifically tailored to medical oncologists
Are we overestimating lifetime cancer risks?
The method employed in Australia to calculate the lifetime risks of cancer diagnosis and mortality…
Browsing: Medical Oncology
COSA 2019: 10-year life satisfaction languishes for Australian men with prostate cancer
A 10-year study of Australian men affected by prostate cancer has found significant numbers of…
Update on Genetic Testing in Cancer and Targeted Therapy
Cancer, a leading cause of mortality, is associated with aberrant genes. Many of the most…
Researchers discover coffee drinkers could halve their risk of liver cancer
A research team from Queen’s University has found that coffee drinkers have a lower risk…
Tailor-made for older adults: New tools improve oncologist-patient relations
A Wilmot Cancer Institute-led study in JAMA Oncology shows that when physicians fully appreciate the concerns of…
How sweet it isn’t: Diminished taste function affects cancer patients’ food intake
The simple pleasure of tasting and savouring food is “an important part of anyone’s daily…
Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe
Genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology, then infusing those cells back…
Scientists crack structure of a novel enzyme linked to cell growth and cancer
RNA, or ribonucleic acid, is present in the cells of all living beings and required…
Potential drug targets for glioblastoma identified
Researchers at Karolinska Institutet in Sweden have identified 10 tumour-specific potential drug targets for the…
To monitor cancer therapy, researchers tag CAR T cells with imaging markers
With CAR T cell therapy, a patient’s own immune cells are genetically modified and inserted…